Regional myocardial perfusion imaging in predicting vessel-related outcome: interplay between the perfusion results and angiographic findings.
Outcome
Regional MPI
SPECT
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
27
05
2022
accepted:
16
08
2022
pubmed:
3
9
2022
medline:
19
11
2022
entrez:
2
9
2022
Statut:
ppublish
Résumé
Despite myocardial perfusion imaging (MPI) by cadmium-zinc-telluride (CZT) single-photon emission computed tomography (SPECT) camera is largely used in the diagnosis and risk stratification of patients with suspected or known coronary artery disease (CAD), no data are available on the prognostic value of a regional MPI evaluation. We evaluated the prognostic value of regional MPI by the CZT camera in predicting clinical outcomes at the vessel level in patients with available angiographic data. Five hundred and forty-one subjects with suspected or known CAD referred to 99mTc-sestamibi gated CZT-SPECT cardiac imaging and with available angiographic data were studied. Both regional total perfusion deficit (TPD) and ischemic TPD (ITPD) were calculated separately for each vascular territory (left anterior descending, left circumflex, and right coronary artery). The outcome end points were cardiac death, target vessel-related myocardial infarction, or late coronary revascularization. The prevalence of CAD ≥ 50%, regional stress TPD, and regional ITPD was significantly higher in vessels with events as compared to those without (both P < 0.001). The receiver operating characteristics area under the curve for regional ITPD for the identification of vessel-related events was 0.81 (95% confidence interval 0.75-0.86). An ITPD value of 2.0% provided the best trade-off for identifying the vessel-related event. At multivariable analysis, both CAD ≥ 50% and ITPD ≥ 2.0% resulted in independent predictors of events. Regional myocardial perfusion assessed by the CZT camera demonstrated good reliability in predicting vessel-related events in patients with suspected or known CAD.
Sections du résumé
BACKGROUND
Despite myocardial perfusion imaging (MPI) by cadmium-zinc-telluride (CZT) single-photon emission computed tomography (SPECT) camera is largely used in the diagnosis and risk stratification of patients with suspected or known coronary artery disease (CAD), no data are available on the prognostic value of a regional MPI evaluation. We evaluated the prognostic value of regional MPI by the CZT camera in predicting clinical outcomes at the vessel level in patients with available angiographic data.
METHODS AND RESULTS
Five hundred and forty-one subjects with suspected or known CAD referred to 99mTc-sestamibi gated CZT-SPECT cardiac imaging and with available angiographic data were studied. Both regional total perfusion deficit (TPD) and ischemic TPD (ITPD) were calculated separately for each vascular territory (left anterior descending, left circumflex, and right coronary artery). The outcome end points were cardiac death, target vessel-related myocardial infarction, or late coronary revascularization. The prevalence of CAD ≥ 50%, regional stress TPD, and regional ITPD was significantly higher in vessels with events as compared to those without (both P < 0.001). The receiver operating characteristics area under the curve for regional ITPD for the identification of vessel-related events was 0.81 (95% confidence interval 0.75-0.86). An ITPD value of 2.0% provided the best trade-off for identifying the vessel-related event. At multivariable analysis, both CAD ≥ 50% and ITPD ≥ 2.0% resulted in independent predictors of events.
CONCLUSIONS
Regional myocardial perfusion assessed by the CZT camera demonstrated good reliability in predicting vessel-related events in patients with suspected or known CAD.
Identifiants
pubmed: 36053295
doi: 10.1007/s00259-022-05948-w
pii: 10.1007/s00259-022-05948-w
pmc: PMC9668771
doi:
Substances chimiques
CdZnTe
0
Cadmium
00BH33GNGH
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
160-167Informations de copyright
© 2022. The Author(s).
Références
Int J Cardiovasc Imaging. 2017 Dec;33(12):2049-2056
pubmed: 28664482
J Nucl Med. 2015 Sep;56(9):1345-50
pubmed: 26159582
J Nucl Cardiol. 2021 Dec;28(6):2827-2839
pubmed: 32383083
J Nucl Cardiol. 2005 Jan-Feb;12(1):66-77
pubmed: 15682367
Comput Math Methods Med. 2021 Oct 16;2021:5288844
pubmed: 34697554
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1091-1100
pubmed: 29470616
Eur Heart J. 2013 Oct;34(38):2949-3003
pubmed: 23996286
Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1698-1704
pubmed: 31836909
Eur Heart J Cardiovasc Imaging. 2016 Jun;17(6):591-5
pubmed: 26985078
J Nucl Cardiol. 2018 Jun;25(3):833-841
pubmed: 27804072
Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):521-529
pubmed: 29372272
J Nucl Cardiol. 2021 Jun;28(3):888-897
pubmed: 31222530
J Nucl Cardiol. 2022 Feb;29(1):46-55
pubmed: 32424676
J Am Coll Cardiol. 2016 Nov 29;68(21):2247-2255
pubmed: 27884241
Eur Heart J. 2019 Jan 14;40(3):237-269
pubmed: 30165617
J Nucl Cardiol. 2012 Apr;19(2):338-46
pubmed: 22302181
J Nucl Cardiol. 2021 Dec;28(6):3025-3037
pubmed: 33000403
J Nucl Med. 2017 Sep;58(9):1459-1463
pubmed: 28450561
J Nucl Cardiol. 2021 Apr;28(2):698-715
pubmed: 31089962
N Engl J Med. 2009 Jan 15;360(3):213-24
pubmed: 19144937
Eur Heart J Cardiovasc Imaging. 2022 Feb 22;23(3):372-380
pubmed: 33247905
J Nucl Cardiol. 2021 Dec;28(6):2927-2936
pubmed: 32500175
J Nucl Cardiol. 2016 Dec;23(6):1251-1261
pubmed: 27387521
Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):296-301
pubmed: 26392197
J Nucl Cardiol. 2017 Feb;24(1):245-251
pubmed: 27510176